Ocugen Inc.

11/26/2021 | Press release | Distributed by Public on 11/26/2021 06:07

Ocugen, Inc. Provides an Update on its Investigational New Drug Application with U.S. FDA to Initiate a Phase 3 Clinical Trial Evaluating COVID-19 Vaccine Candidate COVAXIN™[...]